Improve-the-efficacy-of-clinical-trials-with-RightPatient

Prevent “Professional Patients” in Clinical Trials with an Effective Patient Identifier

COVID-19 has changed reality as we know it since it was first detected. Everything and everyone has been affected, and now, it has reached every continent in the world. But we are hearing all around us that there is light at the end of this very long and dark tunnel. Fortunately, after months of struggle and research, several vaccines have been approved for emergency use. Researchers have worked tirelessly to come up with these vaccines, but there are several factors that could have jeopardized the vaccines – one of these is professional patients that participate in clinical trials. Let’s take a look at what professional patients actually are, how they hamper the integrity of clinical trials, and how an effective patient identifier can help prevent them.

Improve-the-efficacy-of-clinical-trials-with-RightPatient

Clinical trials are more crucial than ever

Clinical trials occur on a regular basis and they are an integral part of healthcare. They lead to new drugs, treatment, and medical devices that reduce recovery times, improve healthcare outcomes, and treat complex or deadly diseases. However, as of now, everyone’s focus is on creating vaccines for COVID-19, which is why clinical trials have been in the spotlight for most of the year.

Clinical trials are quite lengthy and can be risky, but offer the reward of helping scientists arrive at key breakthroughs in healthcare. However, one of the trickiest parts is to recruit patients that fit the requirements of the trial. The volunteers are compensated handsomely and receive treatment for the conditions, but only after thorough background checks are conducted to identify any discrepancies.

That being said, factors such as the existence of “professional patients” can significantly hamper the efficacy and integrity of clinical trials. They can jeopardize years of research, cause millions in losses, and cause promising drugs to remain unapproved. Since there is no effective patient identifier used in clinical trials, professional patients mostly get away with hampering the trials. But what exactly are professional patients, and what are their motivations? 

Professional patients in a nutshell

Professional patients are those individuals that participate in clinical trials quite frequently, and many of them even participate in multiple trials at once. Yes, there are many types of professional patients. However, all of them create data quality issues and inconsistent results and are a hazard to sponsors, CROs (clinical research organizations), and drug companies.

RightPatient-prevents-professional-patients-in-clinical-trials

The first type of professional patients is simply those who have the required medical condition(s) and participate in clinical trials for financial gains. They usually cannot afford treatment for their medical conditions, and thus sign up at multiple facilities, either one at a time or simultaneously. Since they get exposed to multiple untested drugs and receive multiple doses of said drugs, they severely impact the data quality, their own health, and might cause promising drugs to not leave even the initial testing phases.

The other type of professional patients is those who have the required condition(s) but are not in it for the financial benefits. Instead, they falsify information down the line for something far more dangerous. These patients fake results not because they want the treatments; they want regular access to the drugs. These patients are common in treatments regarding addictions. 

The final type of professional patients is those who falsify information. They don’t have the medical condition(s) required by the trial but want to be a part of it. Not only do they falsify information during enrollment, but they can also give false information during the trial itself, which is extremely dangerous! It leads the researchers to make decisions based on incorrect information and can cause the trial to shut down. 

The lack of an effective patient identifier costs millions

Drug companies, sponsors, and CROs pour an enormous amount of time, money, and resources into clinical trials. Unfortunately, all of these are rendered useless by professional patients, and the unreliable data created by these individuals can cost millions. However, the best way to detect and prevent such cases in clinical trials is by using an effective, experienced, and well-reputed patient identifier.

An effective patient identifier ensures the integrity of clinical trials

RightPatient is the leading biometric patient identification platform trusted by several healthcare providers. Used by over 80 hospitals and thousands of clinics, RightPatient is the perfect solution to prevent professional patients in clinical trials.

Patients are assigned a single and unique biometric identity during registration, and they can be identified using mobile devices as well. If professional patients come in, the system can simply red flag them, if registered, and prevent them from participating in the trial, ensuring data integrity in clinical trials. 

Use RightPatient and avoid millions in losses, improve the efficacy of clinical trials, and optimize operations – contact us now to learn how we can help.

Solve-patient-ID-issues-and-prevent-professional-patients-with-RightPatient

Lack of Proper Patient ID Leads to “Professional Patients”

Patient ID issues have always been prevalent in the U.S. healthcare system – we help solve these issues for healthcare providers. Today, however, we won’t talk about patient identification issues that exist in hospitals and healthcare systems – we will focus on the fact that the problem extends beyond the average provider. Unfortunately, many patients take advantage of the lack of a proper patient identity verification system and go repeatedly to their providers’ facilities and take advantage of healthcare services. Did you know that this happens within clinical trials as well? Let’s learn more.

Solve-patient-ID-issues-and-prevent-professional-patients-with-RightPatient

The importance of clinical trials

Clinical trials have a significant impact on conventional healthcare. They lead to breakthroughs that boost healthcare outcomes, reduce recovery times, and can even provide medicine to treat complex and previously untreatable diseases. When considering this topic, COVID-19 would likely pop up in most people’s minds. That’s what the whole world is fighting against currently, and the proposed vaccines developed by leading professionals are going through several clinical trials to determine the effectiveness of the vaccines and whether they have any undesirable side effects.

Thus, the importance of clinical trials is paramount for everyone involved. Likewise, the individuals who volunteer, known as clinical research patients, are essential as well. Let’s see what their motivations are to participate in these activities and what factors are at play that might put the entire trial at risk.

The lack of patient ID systems hurts clinical trials

Patients who participate in clinical trials are well compensated for volunteering. Many do it for altruistic reasons, and while compensation is based on the risks involved, the research is also vetted by an institutional review board. This is done to determine whether anybody enlisted solely for monetary benefits – many patients even enlist in multiple trials or sites. But why do they do so? How do they affect the integrity of the trials? How can an effective patient ID platform prevent this issue?

RightPatient-prevents-fraudulent-participation-from-professional-patients

Professional patients

There are some types of clinical trials where the financial benefits are quite lucrative for individuals who join more than one trial or participate at multiple sites simultaneously. Naturally, many do join these trials and expose themselves to either multiple doses of the same drug or single doses of multiple drugs undergoing testing. These types of patients cannot afford the money to pay for healthcare and thus sign up for multiple trials – they participate to gain access to both the treatment and the compensation. This is just one type of “professional patient” – let’s look at others.

The other type of professional patients falsify information regarding their medical condition – they don’t have the required condition but want to be a part of the trial. They can falsify information regarding the results and effects of the trial to show that they are participating – only to receive the compensation. As you can imagine, their participation in clinical trials may be extremely dangerous.

Another type of professional patient is individuals who actually have the required medical condition but they fake the results – they don’t want to be treated for the condition. These are quite common in trials involving research into treatment for addiction.

The consequences of professional patients

Getting exposed to multiple drugs that are still undergoing testing can lead to adverse effects for the patients. Other than patient safety, the reliability of the trials will be reduced due to integrity failure. Overall, the trials will experience significant losses due to the actions of a few. 

COVID-19 has already claimed over 965,000 lives while experts around the world are racing against time to come up with a cure so that we can finally go back to leading normal lives. If these professional patients participate in the clinical trials for a COVID-19 vaccine, the affected trials will be rendered useless due to the unreliable data these patients will provide. Even when a vaccine is developed it will lose credibility due to professional patients, delaying the most significant breakthrough we need. Is there any way to stop these harmful practices and ensure data integrity of clinical trials?

An accurate patient ID platform is the key

Professional patients are getting smarter about how to enter clinical trials now that information is available on social media. However, if there was an effective patient identification platform in place, it would be enough to prevent professional patients’ participation right from the start. That’s where we can help.

RightPatient is the leading touchless patient identification platform used by healthcare providers. They are using it to protect millions of patient records and prevent duplicates in their EHR systems by ensuring that patients are identified correctly across the care continuum.  

Since RightPatient has both the experience and expertise, it can easily prevent professional patients in clinical trials from fraudulent participation. This leads not only to enhanced safety of the participants within the trials but also makes the data immaculate and reliable – speeding up the trials and reducing losses along the way.

Patient-ID-biometric-modality-realities

How to Choose the Right Biometric Modality for Patient ID in Healthcare

The following post on patient ID in healthcare was submitted by Michael Trader, Co-Founder and President of RightPatient®

We are excited to announce the release of a brand new white paper entitled: Choosing the Most Effective Biometric Solution for Patient Identification in Healthcare (Assessing the characteristics and capabilities of biometric options). The white paper assesses the capabilities and limitations of fingerprint, palm vein, and photo biometrics (iris and facial recognition) for patient ID in healthcare.

Patient-ID-biometric-modality-realities

Misinformation and confusion surrounding biometric patient ID hardware modalities are cleared up in our latest white paper.

The journey to select the most suitable biometric modality for patient identification in healthcare should include an assessment of hardware capabilities and limitations. This white paper was written and published as an educational resource for healthcare organizations to develop a deeper understanding of device characteristics and limitations. Due to persistent misinformation about the ability of select biometric modalities to perform accurate patient ID in healthcare and confusion on the realities of real world results post implementation we feel that this white paper stands as an authoritative guide that should be included in any and all comprehensive due diligence of biometrics.

Over 14 years of experience in real world implementations of fingerprint, palm vein, and photo biometrics has provided us with a wealth of knowledge and research on how these modalities operate when deployed and an authoritative resource to determine which devices can deliver on the promise that effective patient ID solutions offer:

  • Elimination of duplicate medical records and overlays
  • Prevention of medical ID theft and healthcare fraud
  • Increasing and sustaining patient data integrity
  • Increasing patient safety
  • Providing accurate patient ID at ANY point along the care continuum

RightPatient-is-touchless-making-it-the-safest-patient-identification-platform

Did you know that select biometric modalities covered in the white paper do not have the ability to accomplish some of these goals? We encourage you to contact us and request your copy of this important and informative white paper to provide a more thorough background and understanding of biometric patient identification realities versus marketing fluff.

We are confident that you will find value in our research and analysis based on a decade and a half of experience in the biometric identification management industry and extensive experience with all of the modalities covered in the white paper. Please click here to request a copy of the research report. 

How to Choose the Right Biometric Modality for Patient ID in HealthcareMichael Trader is President and Co-Founder of RightPatient®. Michael is responsible for overseeing business development and marketing activities, government outreach, and for providing senior leadership on business and policy issues.